Table 3.
Compounds | BDEd (kcal/mol) | IPd (eV) | IC50 (µmol/L) | ||||
---|---|---|---|---|---|---|---|
4-OH | 11-OH | 4'-OH | 11'-OH | 12'-OH | |||
(a) Gas phase | |||||||
Hispidin | 99.3 | 81.8 | - | - | - | 7.9 | 1.31 ± 0.81 |
3,14'-Bihispidinyl | 89.4 | 82.2 | 106.9 | 82.1 | 87.6 | 7.4 | 0.90 ± 0.61 |
Hypholomine B ( anti) | - | 81.2 | 111.0 | 96.2 | 95.7 | 7.9 | 0.31 ± 0.22 |
1,1-Distyrylpyrylethan | 108.4 | 81.7 | 100.8 | 97.2 | 90.6 | 7.4 | 0.37 ± 0.15 |
(b) PCM | |||||||
Hispidin | 93.9 | 78.2 | - | - | - | 6.3 | 1.31 ± 0.81 |
3,14'-Bihispidinyl | 89.4 | 78.9 | 99.0 | 84.5 | 89.0 | 6.2 | 0.90 ± 0.61 |
Hypholomine B ( anti) | - | 77.4 | 101.1 | 97.6 | 97.0 | 6.3 | 0.31 ± 0.22 |
1,1-Distyrylpyrylethan | 101.3 | 78.8 | 98.5 | 97.5 | 91.2 | 6.2 | 0.37 ± 0.15 |